Cargando…
Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease
Idiopathic Parkinson’s disease (PD) is a complex multifactorial disorder caused by the interplay of both genetic and non-genetic risk factors. Polygenic risk scores (PRSs) are one way to aggregate the effects of a large number of genetic variants upon the risk for a disease like PD in a single quant...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700849/ https://www.ncbi.nlm.nih.gov/pubmed/34946808 http://dx.doi.org/10.3390/genes12121859 |
_version_ | 1784620857192087552 |
---|---|
author | Koch, Sebastian Laabs, Björn-Hergen Kasten, Meike Vollstedt, Eva-Juliane Becktepe, Jos Brüggemann, Norbert Franke, Andre Krämer, Ulrike M. Kuhlenbäumer, Gregor Lieb, Wolfgang Mollenhauer, Brit Neis, Miriam Trenkwalder, Claudia Schäffer, Eva Usnich, Tatiana Wittig, Michael Klein, Christine König, Inke R. Lohmann, Katja Krawczak, Michael Caliebe, Amke |
author_facet | Koch, Sebastian Laabs, Björn-Hergen Kasten, Meike Vollstedt, Eva-Juliane Becktepe, Jos Brüggemann, Norbert Franke, Andre Krämer, Ulrike M. Kuhlenbäumer, Gregor Lieb, Wolfgang Mollenhauer, Brit Neis, Miriam Trenkwalder, Claudia Schäffer, Eva Usnich, Tatiana Wittig, Michael Klein, Christine König, Inke R. Lohmann, Katja Krawczak, Michael Caliebe, Amke |
author_sort | Koch, Sebastian |
collection | PubMed |
description | Idiopathic Parkinson’s disease (PD) is a complex multifactorial disorder caused by the interplay of both genetic and non-genetic risk factors. Polygenic risk scores (PRSs) are one way to aggregate the effects of a large number of genetic variants upon the risk for a disease like PD in a single quantity. However, reassessment of the performance of a given PRS in independent data sets is a precondition for establishing the PRS as a valid tool to this end. We studied a previously proposed PRS for PD in a separate genetic data set, comprising 1914 PD cases and 4464 controls, and were able to replicate its ability to differentiate between cases and controls. We also assessed theoretically the prognostic value of the PD-PRS, i.e., its ability to predict the development of PD in later life for healthy individuals. As it turned out, the PD-PRS alone can be expected to perform poorly in this regard. Therefore, we conclude that the PD-PRS could serve as an important research tool, but that meaningful PRS-based prognosis of PD at an individual level is not feasible. |
format | Online Article Text |
id | pubmed-8700849 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87008492021-12-24 Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease Koch, Sebastian Laabs, Björn-Hergen Kasten, Meike Vollstedt, Eva-Juliane Becktepe, Jos Brüggemann, Norbert Franke, Andre Krämer, Ulrike M. Kuhlenbäumer, Gregor Lieb, Wolfgang Mollenhauer, Brit Neis, Miriam Trenkwalder, Claudia Schäffer, Eva Usnich, Tatiana Wittig, Michael Klein, Christine König, Inke R. Lohmann, Katja Krawczak, Michael Caliebe, Amke Genes (Basel) Article Idiopathic Parkinson’s disease (PD) is a complex multifactorial disorder caused by the interplay of both genetic and non-genetic risk factors. Polygenic risk scores (PRSs) are one way to aggregate the effects of a large number of genetic variants upon the risk for a disease like PD in a single quantity. However, reassessment of the performance of a given PRS in independent data sets is a precondition for establishing the PRS as a valid tool to this end. We studied a previously proposed PRS for PD in a separate genetic data set, comprising 1914 PD cases and 4464 controls, and were able to replicate its ability to differentiate between cases and controls. We also assessed theoretically the prognostic value of the PD-PRS, i.e., its ability to predict the development of PD in later life for healthy individuals. As it turned out, the PD-PRS alone can be expected to perform poorly in this regard. Therefore, we conclude that the PD-PRS could serve as an important research tool, but that meaningful PRS-based prognosis of PD at an individual level is not feasible. MDPI 2021-11-23 /pmc/articles/PMC8700849/ /pubmed/34946808 http://dx.doi.org/10.3390/genes12121859 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Koch, Sebastian Laabs, Björn-Hergen Kasten, Meike Vollstedt, Eva-Juliane Becktepe, Jos Brüggemann, Norbert Franke, Andre Krämer, Ulrike M. Kuhlenbäumer, Gregor Lieb, Wolfgang Mollenhauer, Brit Neis, Miriam Trenkwalder, Claudia Schäffer, Eva Usnich, Tatiana Wittig, Michael Klein, Christine König, Inke R. Lohmann, Katja Krawczak, Michael Caliebe, Amke Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease |
title | Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease |
title_full | Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease |
title_fullStr | Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease |
title_full_unstemmed | Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease |
title_short | Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease |
title_sort | validity and prognostic value of a polygenic risk score for parkinson’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700849/ https://www.ncbi.nlm.nih.gov/pubmed/34946808 http://dx.doi.org/10.3390/genes12121859 |
work_keys_str_mv | AT kochsebastian validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT laabsbjornhergen validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT kastenmeike validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT vollstedtevajuliane validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT becktepejos validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT bruggemannnorbert validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT frankeandre validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT kramerulrikem validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT kuhlenbaumergregor validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT liebwolfgang validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT mollenhauerbrit validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT neismiriam validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT trenkwalderclaudia validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT schaffereva validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT usnichtatiana validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT wittigmichael validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT kleinchristine validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT koniginker validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT lohmannkatja validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT krawczakmichael validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease AT caliebeamke validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease |